Users Online: 1853 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size


Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others


Scar size and effectiveness of Bacillus Calmette Guerin (BCG) vaccination in the prevention of tuberculosis and leprosy: A case-control study

Zodpey Sanjoy P, Shrikhande Sunanda N, Kulkarni Shyam W, Maldhure Bhagirath R

Year : 2007| Volume: 51| Issue : 3 | Page no: 184-189

   This article has been cited by
1 Immunogenicity of the tuberculosis vaccine MVA85A is reduced by coadministration with EPI vaccines in a randomized controlled trial in gambian infants
Ota, M.O.C. and Odutola, A.A. and Owiafe, P.K. and Donkor, S. and Owolabi, O.A. and Brittain, N.J. and Williams, N. and Rowland-Jones, S. and Hill, A.V.S. and Adegbola, R.A. and McShane, H.
Science Translational Medicine. 2011; 3(88)
[Pubmed]  [Google Scholar]
2 BCG vaccination and leprosy protection: Review of current evidence and status of BCG in leprosy control
Merle, C.S., Cunha, S.S., Rodrigues, L.C.
Expert Review of Vaccines. 2010; 9(2): 209-222
[Pubmed]  [Google Scholar]
3 Tuberculosis case-contact research in endemic tropical settings: Design, conduct, and relevance to other infectious diseases
Hill, P.C., Ota, M.O.C.
The Lancet Infectious Diseases. 2010; 10(10): 723-732
[Pubmed]  [Google Scholar]


Read this article